Wyden Statement on Senate Passage of Partisan, Harmful Reconciliation Bill
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued a statement following Senate passage of a reconciliation bill that would repeal parts of the Affordable Care Act: “The only good news about this flawed reconciliation bill is that it’s about to meet the President’s veto pen,” Wyden said. “The campaign against women’s health and the […]
Wyden Blasts Latest Attempt to Defund Planned Parenthood
At the heart of the reconciliation proposal before the Senate is yet another partisan attempt to undermine women’s health by denying funding to Planned Parenthood. My view is to take away health care choices from women that have nothing to do with abortion, particular after the attack in Colorado last week. In my view, to […]
Wyden Blasts Partisan Reconciliation Bill in Floor Speech
It is reassuring news that the reconciliation bill coming before the Senate is guaranteed to get the veto stamp on the President’s desk. That’s because it undermines women’s health, it would mean millions more Americans without insurance, and it threatens to send premiums shooting upward. With my time today, I want to address a few […]
Wyden Statement at Finance Committee Hearing On OECD BEPS
Today’s Finance Committee hearing on international tax comes just two weeks after the headlines announced yet another tax inversion. This time it’s Pfizer merging with Allergan and moving its headquarters overseas in pursuit of a lower tax bill. Pfizer’s move is further proof of what everybody in this room knows to be true — our […]
Wyden Press Conference Remarks on Investigation into Gilead’s Pricing of Hepatitis Drug Sovaldi
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., delivered the following remarks at a press conference with Senator Chuck Grassley, R-Iowa, a senior member of the committee, following the release of their bipartisan investigation into the pricing of Gilead Sciences blockbuster Hepatitis C drug, Sovaldi. Video of the press conference can be found […]
Wyden-Grassley Sovaldi Investigation Finds Revenue-Driven Pricing Strategy Behind $84,000 Hepatitis Drug
18-Month Investigation Reveals a Pricing and Marketing Strategy Designed to Maximize Revenue with Little Concern for Access or Affordability Report Includes Landmark Release of Medicaid Data: In 2014, More than $1 Billion Spent by Medicaid Programs on Sovaldi Treated Less than 2.4 Percent of Enrolled Patients with Hepatitis C Medicare Spent More on Gilead Hepatitis […]
Wyden Statement on Pfizer-Allergan Merger
Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement on the proposed merger between pharmaceutical companies Pfizer and Allergan: “The Treasury Department has made it very clear that its efforts to halt the inversion virus and stop the further erosion of our tax base can only go so far. The only […]
Wyden Statement Regarding New Treasury Guidance on Inversions
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today issued the following statement: “We welcome efforts from Treasury to curb overseas tax inversions. Ultimately it’s up to Congress to deliver tax policy that better equips companies to compete and succeed by staying in the U.S. And the only way to get that done, and […]
Wyden Requests Update on 1332 Waiver Implementation from HHS
WASHINGTON – Senate Finance Committee Ranking Member Ron Wyden, D-Ore., today sent a letter to Department of Health and Human Services (HHS) Secretary Sylvia Mathews Burwell to inquire about the Department’s preparations for when states are allowed to apply for the waivers in 2017. “State Innovation Waivers allow pioneering states to take the reins and come […]
Wyden Hearing Statement on Physician-Owned Distributorships
When you walk into a doctor’s office, you’re putting an extraordinary level of trust — and maybe even your life — in your physician’s hands. Today the Finance Committee will hear about one type of business called a physician-owned distributorship that in some cases might violate that trust with dangerous and life-threatening consequences. […]